logo

La Jolla Pharmaceutical Co (LJPC)



Trade LJPC now with
  Date
  Headline
11/17/2021 8:05:18 AM La Jolla Pharmaceutical Company To Commence Share Repurchase Plan for Up To $10 Mln Of Common Stock
11/4/2021 8:51:21 AM La Jolla Pharma Q3 Loss/shr Narrows To $0.08 From $0.43 Prior Year
9/10/2021 8:08:55 AM La Jolla Pharma Appoints Tony Hodges As Chief Medical Officer
8/5/2021 8:41:50 AM La Jolla Pharma Q2 Total Revenue Rises To $16.1 Mln From $5.8 Mln Prior Year
5/7/2021 9:00:38 AM La Jolla Pharmaceutical Q1 Net Income $14.4 Mln Or $0.42/Shr Vs Loss $8.6 Mln Or $0.32/Shr Last Year
1/12/2021 7:12:56 AM La Jolla Pharma Announces Exclusive Licensing Agreement For GIAPREZA And XERAVA In Europe
11/9/2020 5:40:01 PM La Jolla Pharmaceutical Q3 Loss/Shr $0.43 Vs Loss $1.08 Prior Year
4/3/2020 8:39:28 AM La Jolla Provide GIAPREZA For Named Patient Emergency Use In Patients With Septic Shock Due To COVID-19
1/9/2020 8:13:28 AM La Jolla Pharmaceutical Three-month Preliminary GIAPREZA Net Sales $7.2 Mln
2/12/2018 6:33:27 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY19 Rev. Estimate To 44.3 M From 54.1 M
2/12/2018 6:33:09 AM Jefferies Is Cutting La Jolla Pharmaceutical Co (LJPC) FY18 Rev. Estimate To 6.7 M From 52.9 M
2/12/2018 6:32:33 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY19 Estimate To -2.92 From -2.44
2/12/2018 6:32:13 AM Jefferies Is Lowering La Jolla Pharmaceutical Co (LJPC) FY18 Estimate To -4.28 From -2.38
2/12/2018 6:31:08 AM Jefferies Lowers La Jolla Pharmaceutical Co (LJPC) To Underperform From Buy With $29 Down From $40 Price Target
8/10/2016 8:22:56 AM Jefferies Is Raising La Jolla Pharmaceutical Co (LJPC) 2018 Estimate To -1.88 From -2.04
8/10/2016 8:22:38 AM Jefferies Is Raising La Jolla Pharmaceutical Co (LJPC) 2017 Estimate To -3.82 From -3.99